New Study Says Lab Test Can Reliably Identify Bleeding Risk in Xarelto Patients
Plaintiff attorneys say three recently decided Xarelto bellwether trials may have ended differently if jurors would have access
Learn MoreXarelto Bleeding Risks
FDA Reviewing Lower-Dose Option of Xarelto
The U.S. Food and Drug Administration is currently reviewing a new low-dose version of the blood thinner Xarelto
Learn More ISMP: Xarelto Adverse Reports Exceed 15,000 in 2016
According to the Institute for Safe Medication Practices (ISMP), the U.S. Food and Drug Administration (FDA) received 15,043
Learn More
Study Says Severe Bleeding More Common with Xarelto Than with Pradaxa
According to a cohort study published recently in JAMA Internal Medicine, patients using Xarelto (rivaroxaban) are more likely
Learn More J&J, Bayer Prevail in First Xarelto Trial, 18,000 More Suits to Come
Although Johnson & Johnson and Bayer AG won the first battle when a jury found that the companies
Learn More